HeartSciences (HSCS) Competitors $3.01 -0.33 (-9.88%) Closing price 04:00 PM EasternExtended Trading$3.05 +0.04 (+1.33%) As of 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. STRR, VVOS, COCH, ICU, RVP, NRXS, PETV, IRIX, DRIO, and NXGLShould you be buying HeartSciences stock or one of its competitors? The main competitors of HeartSciences include Hudson Global (STRR), Vivos Therapeutics (VVOS), Envoy Medical (COCH), SeaStar Medical (ICU), Retractable Technologies (RVP), NeurAxis (NRXS), PetVivo (PETV), IRIDEX (IRIX), DarioHealth (DRIO), and NexGel (NXGL). These companies are all part of the "medical equipment" industry. HeartSciences vs. Its Competitors Hudson Global Vivos Therapeutics Envoy Medical SeaStar Medical Retractable Technologies NeurAxis PetVivo IRIDEX DarioHealth NexGel Hudson Global (NASDAQ:STRR) and HeartSciences (NASDAQ:HSCS) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Which has more risk and volatility, STRR or HSCS? Hudson Global has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.57, indicating that its share price is 157% more volatile than the S&P 500. Is STRR or HSCS more profitable? HeartSciences has a net margin of 0.00% compared to Hudson Global's net margin of -2.81%. Hudson Global's return on equity of -3.81% beat HeartSciences' return on equity.Company Net Margins Return on Equity Return on Assets Hudson Global-2.81% -3.81% -2.84% HeartSciences N/A -437.83%-148.58% Which has preferable valuation & earnings, STRR or HSCS? Hudson Global has higher revenue and earnings than HeartSciences. Hudson Global is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHudson Global$140.06M0.18-$4.77M-$1.30-7.21HeartSciencesN/AN/A-$8.77M-$9.36-0.32 Do analysts prefer STRR or HSCS? Hudson Global presently has a consensus target price of $5.00, suggesting a potential downside of 46.64%. HeartSciences has a consensus target price of $13.00, suggesting a potential upside of 331.89%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts plainly believe HeartSciences is more favorable than Hudson Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hudson Global 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00HeartSciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in STRR or HSCS? 3.8% of Hudson Global shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 33.5% of Hudson Global shares are owned by insiders. Comparatively, 1.8% of HeartSciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer STRR or HSCS? In the previous week, HeartSciences had 1 more articles in the media than Hudson Global. MarketBeat recorded 5 mentions for HeartSciences and 4 mentions for Hudson Global. HeartSciences' average media sentiment score of 1.22 beat Hudson Global's score of 0.15 indicating that HeartSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hudson Global 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HeartSciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHeartSciences beats Hudson Global on 9 of the 15 factors compared between the two stocks. Get HeartSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeartSciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.60M$2.18B$5.86B$10.15BDividend YieldN/AN/A5.68%4.59%P/E Ratio-0.3635.7174.5225.93Price / SalesN/A10.27536.78122.58Price / CashN/A58.3137.5660.44Price / Book16.7211.6512.166.29Net Income-$8.77M-$63.67M$3.28B$270.77M7 Day Performance-9.61%-0.25%0.98%3.36%1 Month Performance-11.21%5.37%7.20%6.41%1 Year Performance7.89%37.29%63.06%28.26% HeartSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeartSciences3.0872 of 5 stars$3.01-9.9%$13.00+331.9%+18.4%$7.60MN/A-0.3610News CoveragePositive NewsEarnings ReportGap DownSTRRHudson Global1.0894 of 5 stars$9.27-3.7%$5.00-46.1%+104.8%$29.99M$137.86M-7.131,300Gap UpHigh Trading VolumeVVOSVivos Therapeutics2.8141 of 5 stars$3.87+1.0%$4.92+27.0%+19.7%$29.03M$15.03M-2.30160Analyst ForecastShort Interest ↓COCHEnvoy Medical2.0953 of 5 stars$1.28-2.3%$9.25+622.7%-59.1%$27.55M$220K-0.9034Short Interest ↑ICUSeaStar Medical0.4021 of 5 stars$0.88+4.6%N/A-83.0%$24.44M$140K-0.332Short Interest ↓RVPRetractable Technologies1.2364 of 5 stars$0.81+1.6%N/A-10.3%$24.22M$38.16M-1.50240Short Interest ↑NRXSNeurAxis2.0116 of 5 stars$2.45+1.2%$7.00+185.7%-21.9%$24.19M$3.22M-1.3319Short Interest ↑PETVPetVivoN/A$0.85+3.2%N/A+44.8%$23.72M$1.05M-1.8920News CoverageIRIXIRIDEX0.7175 of 5 stars$1.36-1.4%N/A-32.5%$23.11M$49.74M-4.12120DRIODarioHealth1.8738 of 5 stars$9.14-0.7%$40.00+337.6%-55.1%$20.79M$27.15M-0.69200Positive NewsNXGLNexGel0.8956 of 5 stars$2.34+5.4%N/A-10.5%$18.88M$8.69M-5.8510 Related Companies and Tools Related Companies Hudson Global Competitors Vivos Therapeutics Competitors Envoy Medical Competitors SeaStar Medical Competitors Retractable Technologies Competitors NeurAxis Competitors PetVivo Competitors IRIDEX Competitors DarioHealth Competitors NexGel Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
